Alkylphosphocholines: a new class of membrane-active anticancer agents.
Hilgard
P
P
ASTA Medica AG, Frankfurt am Main.
Klenner
T
T
Stekar
J
J
Unger
C
C
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002454:Cell Differentiation / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007107:Immune System / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy*; D010767:Phosphorylcholine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D051381:Rats; D014407:Tumor Cells, Cultured; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D010767:Phosphorylcholine; C039128:miltefosine; D011493:Protein Kinase C; D010738:Type C Phospholipases